Radovich Peter
PRESIDENT AND COO at MIRM; Officer at Global Blood Therapeutics, Inc.
- Sold, on record
- $7.1M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Mar 16, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MIRMMirum Pharmaceuticals, Inc.PRESIDENT AND COO
- Global Blood Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MIRM66,871 shares
- Global Blood Therapeutics, Inc.60,722 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MIRMNo planFeb 3, 2025 2025
Sold 2,627 shares at $48.22 ($127k)
Radovich Peter, PRESIDENT AND COO
No 10b5-1 planSold 8.9% of holdings ($1.4M position)26,961 shares left1.4x usual sizeFiling
- 2 Form 144 notice MIRMNoticeMar 4, 2025 +29 days
Filed to sell 14,850 shares ($676k)
Radovich Peter, Officer
No 10b5-1 plan7.4x usual sizeFiling
- 3 Form 4 sale MIRMUnusualMar 4, 2025 same day
Sold 14,850 shares at $45.58 ($677k)
Radovich Peter, PRESIDENT AND COO
No 10b5-1 planSold 55.1% of holdings ($1.2M position)12,111 shares left7.4x usual sizeFollows a Form 144Filing
- 4 Form 4 sale MIRMUnusualMar 17, 2025 +13 days
Sold 7,879 shares at $44.21 ($348k)
Radovich Peter, PRESIDENT AND COO
No 10b5-1 planSold 29.7% of holdings ($1.2M position)18,672 shares left3.4x usual sizeFiling
- 5 Form 4 sale MIRMNo planJan 22, 2026 +311 days
Sold 2,382 shares at $93.33 ($222k)
Radovich Peter, PRESIDENT AND COO
No 10b5-1 planSold 10.3% of holdings ($2.2M position)20,679 shares left0.7x usual sizeFiling
- 6 Form 4 sale MIRMNo planJan 26, 2026 +4 days
Sold 3,143 shares at $96.19 ($302k)
Radovich Peter, PRESIDENT AND COO
No 10b5-1 planSold 11.9% of holdings ($2.5M position)23,286 shares left1.1x usual sizeFiling
- 7 Form 4 sale MIRMNo planFeb 2, 2026 +7 days
Sold 2,631 shares at $103.30 ($272k)
Radovich Peter, PRESIDENT AND COO
No 10b5-1 planSold 11.3% of holdings ($2.4M position)20,655 shares left0.8x usual sizeFiling
- 8 Form 4 sale MIRMUnusualMar 16, 2026 +42 days
Sold 16,515 shares at $91.98 ($1.5M)
Radovich Peter, PRESIDENT AND COO
No 10b5-1 planSold 29.1% of holdings ($5.2M position)40,272 shares left5.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 17, 2026 | MIRM | PRESIDENT AND COO | Form 4 sale | 16,515 | $1.5M | 29.1% | Unusual | SEC |
| Feb 2, 2026 | Feb 3, 2026 | MIRM | PRESIDENT AND COO | Form 4 sale | 2,631 | $272k | 11.3% | No plan | SEC |
| Jan 26, 2026 | Jan 27, 2026 | MIRM | PRESIDENT AND COO | Form 4 sale | 3,143 | $302k | 11.9% | No plan | SEC |
| Jan 22, 2026 | Jan 23, 2026 | MIRM | PRESIDENT AND COO | Form 4 sale | 2,382 | $222k | 10.3% | No plan | SEC |
| Mar 17, 2025 | Mar 18, 2025 | MIRM | PRESIDENT AND COO | Form 4 sale | 7,879 | $348k | 29.7% | Unusual | SEC |
| Mar 4, 2025 | Mar 5, 2025 | MIRM | PRESIDENT AND COO | Form 4 sale | 14,850 | $677k | 55.1% | Unusual | SEC |
| Mar 4, 2025 | Mar 4, 2025 | MIRM | Officer | Form 144 notice | 14,850 | $676k | Notice | SEC | |
| Feb 3, 2025 | Feb 4, 2025 | MIRM | PRESIDENT AND COO | Form 4 sale | 2,627 | $127k | 8.9% | No plan | SEC |
| Jan 24, 2025 | Jan 27, 2025 | MIRM | PRESIDENT AND COO | Form 4 sale | 3,177 | $152k | 9.7% | No plan | SEC |
| Jan 7, 2025 | Jan 8, 2025 | MIRM | PRESIDENT AND COO | Form 4 sale | 1,998 | $86k | 6.9% | No plan | SEC |
| Mar 25, 2024 | Mar 25, 2024 | MIRM | PRESIDENT AND COO | Form 4 sale | 4,303 | $111k | 12.9% | Unusual | SEC |
| Feb 2, 2024 | Feb 5, 2024 | MIRM | PRESIDENT AND COO | Form 4 sale | 1,790 | $47k | 4.9% | No plan | SEC |
| Jan 8, 2024 | Jan 9, 2024 | MIRM | CHIEF OPERATING OFFICER | Form 4 sale | 1,408 | $39k | 3.7% | No plan | SEC |
| Jul 3, 2023 | Jul 5, 2023 | MIRM | Chief Operating Officer | Form 4 sale | 1,425 | $37k | 3.6% | No plan | SEC |
| Jan 9, 2023 | Mar 18, 2024 | MIRM | PRESIDENT AND COO | Form 4 sale | 1,379 | $28k | 4.0% | No plan | SEC |
| Oct 1, 2021 | Oct 1, 2021 | MIRM | Chief Operating Officer | Form 4 sale | 1,364 | $26k | 10.8% | Plan not stated | SEC |
| Feb 1, 2018 | Feb 2, 2018 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 812 | $47k | 10.6% | Plan not stated | SEC |
| Jan 23, 2018 | Jan 25, 2018 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 30,000 | $1.8M | 89.3% | Unusual | SEC |
| Jan 10, 2018 | Jan 11, 2018 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 15,000 | $750k | 84.8% | Unusual | SEC |
| Oct 30, 2017 | Oct 31, 2017 | Global Blood Therapeutics, Inc. | Senior VP, Operations | Form 4 sale | 12,500 | $438k | 100.0% | Unusual | SEC |
| Aug 31, 2017 | Sep 5, 2017 | Global Blood Therapeutics, Inc. | Officer | Form 4 sale | 2,410 | $72k | 47.3% | Unusual | SEC |